S&P 500 Futures
(0.58%) 5 076.00 points
Dow Jones Futures
(0.33%) 38 193 points
Nasdaq Futures
(0.81%) 17 580 points
Oil
(0.67%) $79.53
Gas
(2.33%) $1.977
Gold
(-0.18%) $2 306.90
Silver
(-1.15%) $26.44
Platinum
(0.36%) $958.30
USD/EUR
(0.15%) $0.934
USD/NOK
(0.51%) $11.09
USD/GBP
(0.08%) $0.799
USD/RUB
(-1.49%) $91.87

Realaus laiko atnaujinimai Tongfang Kontafarma [1312.HK]

Birža: HKSE Sektorius: Construction Pramonė: Drug Manufacturers—Specialty & Generic
Atnaujinta30 bal. 2024 @ 10:58

6.67% HKD 0.0320

Live Chart Being Loaded With Signals

Commentary (30 bal. 2024 @ 10:58):

Tongfang Kontafarma Holdings Limited, an investment holding company, engages in the manufacture and sale of prescription drugs and laboratory related products in Mainland China, Singapore, Taiwan, and the United States...

Stats
Šios dienos apimtis 6 000.00
Vidutinė apimtis 531 310
Rinkos kapitalizacija 178.52M
EPS HKD0 ( 2024-03-27 )
Last Dividend HKD0.00400 ( 2013-05-27 )
Next Dividend HKD0 ( N/A )
P/E -3.20
ATR14 HKD0 (0.00%)

Tongfang Kontafarma Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Tongfang Kontafarma Finansinės ataskaitos

Annual 2023
Pajamos: HKD809.11M
Bruto pelnas: HKD464.54M (57.41 %)
EPS: HKD-0.00520
FY 2023
Pajamos: HKD809.11M
Bruto pelnas: HKD464.54M (57.41 %)
EPS: HKD-0.00520
FY 2022
Pajamos: HKD894.06M
Bruto pelnas: HKD506.22M (56.62 %)
EPS: HKD-0.0197
FY 2021
Pajamos: HKD961.09M
Bruto pelnas: HKD482.89M (50.24 %)
EPS: HKD-0.00270

Financial Reports:

No articles found.

Tongfang Kontafarma Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)

Tongfang Kontafarma Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 4.38 - low (45.70%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future
Information
First Dividend HKD0.00400 2012-05-28
Last Dividend HKD0.00400 2013-05-27
Next Dividend HKD0 N/A
Payout Date 2013-06-13
Next Payout Date N/A
# dividends 2 --
Total Paid Out HKD0.00800 --
Avg. Dividend % Per Year 0.00% --
Score 1.18 --
Div. Sustainability Score 4.38
Div.Growth Potential Score 0
Div. Directional Score 2.18 --
Next Divdend (Est)
(2025-03-31)
HKD0 Estimate 0.00 %
Dividend Stability
0.01 Very Bad
Dividend Score
1.18
Pay Frequency
Annually
Yearly Payout
Year Amount Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for HKSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
2368.HK Ex Dividend Knight 2023-08-25 Semi-Annually 0 0.00%
1357.HK Ex Dividend Junior 2023-06-05 Insufficient data to determine frequency 0 0.00%
0398.HK Ex Dividend Knight 2023-09-29 Semi-Annually 0 0.00%
6690.HK Ex Dividend Knight 2023-07-24 Annually 0 0.00%
1905.HK Ex Dividend Knight 2023-10-20 Semi-Annually 0 0.00%
0934.HK Ex Dividend Knight 2023-09-14 Semi-Annually 0 0.00%
0057.HK Ex Dividend Knight 2023-09-01 Semi-Annually 0 0.00%
2885.HK Ex Dividend Junior 2023-06-15 Annually 0 0.00%
1501.HK Ex Dividend Junior 2023-05-24 Annually 0 0.00%
0552.HK Ex Dividend Junior 2023-07-03 Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-0.03561.500-0.713-1.069[0 - 0.5]
returnOnAssetsTTM-0.02501.200-0.835-1.002[0 - 0.3]
returnOnEquityTTM-0.03971.500-1.553-2.33[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM1.5160.8007.425.94[1 - 3]
quickRatioTTM1.1400.8008.006.40[0.8 - 2.5]
cashRatioTTM0.2021.5009.9910.00[0.2 - 2]
debtRatioTTM0.0686-1.5008.86-10.00[0 - 0.6]
interestCoverageTTM-14.971.000-6.66-6.66[3 - 30]
operatingCashFlowPerShareTTM0.0004222.0010.0010.00[0 - 30]
freeCashFlowPerShareTTM-0.004312.00-0.00215-0.00431[0 - 20]
debtEquityRatioTTM0.112-1.5009.55-10.00[0 - 2.5]
grossProfitMarginTTM0.5771.0003.723.72[0.2 - 0.8]
operatingProfitMarginTTM-0.2031.000-6.06-6.06[0.1 - 0.6]
cashFlowToDebtRatioTTM0.01991.000-1.001-1.001[0.2 - 2]
assetTurnoverTTM0.7030.8008.656.92[0.5 - 2]
Total Score4.38

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-4.131.000-0.5180[1 - 100]
returnOnEquityTTM-0.03972.50-0.998-2.33[0.1 - 1.5]
freeCashFlowPerShareTTM-0.004312.00-0.00144-0.00431[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM0.0004222.0010.0010.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM0.03161.500-3.120[0.5 - 2]
operatingCashFlowSalesRatioTTM0.001941.000-2.450[0.1 - 0.5]
Total Score-0.0152

Tongfang Kontafarma

Tongfang Kontafarma Holdings Limited, an investment holding company, engages in the manufacture and sale of prescription drugs and laboratory related products in Mainland China, Singapore, Taiwan, and the United States. The company operates in Pharmaceutical Business and Fitness Business segments. It also offers chemical drugs and prescribed traditional Chinese medicines; operates fitness centers; operates in the franchise business; and provides consultation services for fitness and health activities. The company trades in laboratory related products; researches and develops medical products; and offers corporate advisory services. As of December 31, 2021, it operated 12 fitness centers and 2 yoga center in Taiwan; and 10 fitness centers in Singapore. The company was formerly known as Allied Cement Holdings Limited and changed its name to Tongfang Kontafarma Holdings Limited in August 2016. The company was founded in 1993 and is headquartered in Wan Chai, Hong Kong. Tongfang Kontafarma Holdings Limited is a subsidiary of China Health Management Investment Limited.

Apie Signalai gyvai

Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.

Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.